441
Participants
Start Date
October 31, 2010
Primary Completion Date
January 31, 2013
Study Completion Date
February 28, 2013
ferric citrate, ca acetate, sevelamer carbonate, placebo
All intervention doses will be based on serum phosphorus levels and/or drug label requirements
Brookdale Physician's Dialysis Associates, Brooklyn
University of Pennsylvania Health System, Philadelphia
Rockville Dialysis Center, Rockville
Clinical Research & Consulting Center, LLC, Fairfax
Nephrology Associates of Northern Virginia, Inc., Fairfax
Nephrology Clinical Research Center, Charlottesville
McGuire VA Medical Center, Richmond
Peninsula Kidney Associates, Hampton
Wake Forest University School of Medicine, Winston-Salem
Duke University Medical Center Division of Nephrology, Durham
Metrolina Nephrology Associates, PA, Charlotte
Trial Management Associates, Wilmington
Mountain Kidney and Hypertension Associates, PA, Asheville
Atlanta Nephrology Referral Center, Decatur
Kidney Care Associates, LLC, Augusta
Mayo Clinic, Jacksonville
Pines Clinical Research, Inc., Pembroke Pines
ASA Clinical Research, LLC, Jupiter
PAB Clinical Research, Brandon
Ocala Kidney Group, Ocala
Nephrology Associates, PC, Nashville
Southeast Renal Research Institute Nephrology Associates, Chattanooga
The Ohio State University Division of Nephrology, Columbus
Cleveland Clinic Foundation Q7-150 Nephrology, Cleveland
Clinical Research Limited, Canton
Division of Nephrology and Hypertension Department of Internal Medicine University of Cincinnati College of Medicine, Cincinnati
Nephrology Specialists, PC, Michigan City
Nephrology Hypertension Clinic, Southgate
Henry Ford Hospital, Detroit
Michigan Kidney Consultants, PC, Pontiac
Medical College of Wisconsin Froedert Memorial Lutheran Hospital Division of Nephrology, Milwaukee
Circle Medical Management, Chicago
Kansas City VA Medical Center, Kansas City
LSU Health Sciences Center Section of Nephrology and Hypertension Department of Internal Medicine, New Orleans
DaVita, Oklahoma City
UT Southwestern Medical Center at Dallas, Dallas
Kidney Associates, Houston
Nephrology, PA, Houston
Kidney Specialists of North Houston, PLLC, The Woodlands
Western Nephrology, Westminster
University of Colorado Denver, Aurora
University of Utah Health Sciences Center, Salt Lake City
Southwest Clinical Research Institute, LLC, Tempe
Tower Nephrology Medical Group, Los Angeles
Veterans Administration Greater Los Angeles Healthcare System, West Los Angeles, Los Angeles
American Institute of Research, Whittier
Apex Research of Riverside, Riverside
Tufts Medical Center, Boston
Pioneer Valley Nephrology, Holyoke
Western New England Renal & Transplant Associates, Springfield
Vanderbilt University Medical Center Clinical Trials Center, Nashville
University of Vermont/ Fletcher Allen Health Care; Renal Services, Burlington
Department of Nephrology and Hypertension Brazilai Medical Center, Ashkelon
Tel Aviv Sourasky Medical Center Nephrology Department, Tel Aviv
RCMI-Clinical Research Center Medical Sciences Campus University of Puerto Rico, Rio Piedras
Puerto Rico Renal Health & Research Center, Inc/ Atlantic Healthcare Group, Inc, Trujillo Alto
Lead Sponsor
Keryx Biopharmaceuticals
INDUSTRY